市場調查報告書
商品編碼
1267336
腦膜炎診斷測試全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測Global Meningitis Diagnostic Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
全球對腦膜炎診斷測試市場的需求將從 2022 年的 2.09 億美元增長到 2030 年的近 3.5377 億美元,預計在 2023-2030 年研究期間達到 6.8% 的複合年增長率。
腦膜炎是大腦和脊髓周圍稱為腦膜的膜的炎症。 細菌、病毒、寄生蟲和真菌會導致這種感染。 腦膜炎因其傳染性而成為全球關注的話題。 因此,政府正在積極努力通過建立高科技診斷設施和醫院來治療患者,以根除腦膜炎。 腦膜炎是使用實驗室儀器診斷的,例如快速乳膠凝集試驗、高度複雜的 PCR 和免疫測定。
由於消費者對疾病早期檢測需求的認識不斷提高,對及時診斷和高檢測準確性的需求不斷增加,預計該市場將會擴大。 此外,增加診斷設施和政府資助以減輕疾病負擔正在推動市場需求。 此外,腦膜炎診斷市場的發展正在受到 PCR 和下一代測序等新的尖端技術的推動,這將使診斷變得更便宜。 在預測期內,新興國家診斷實驗室設施短缺、腦膜炎診斷專家短缺等幾個問題預計將限制市場擴張。
這份研究報告解釋了波特的五力模型、市場吸引力分析和價值鏈分析。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外,這些工具還能夠全面評估全球腦膜炎診斷測試市場的每個細分市場。 腦膜炎診斷測試行業的發展和趨勢為這項研究提供了一種整體方法。
本節提供了按國家和地區劃分的腦膜炎診斷測試市場細分的詳細數據,以幫助確定每種產品/服務的目標受眾和未來商機。
本節涵蓋區域展望,重點介紹北美、歐洲、亞太地區、拉丁美洲、中東和非洲腦膜炎診斷檢測市場當前和未來的需求。 此外,我們還關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 腦膜炎診斷測試市場的主要參與者包括 Thermo Fisher Scientific Inc.、Bio-Rad Laboratories Inc.、Abbott、ELITechGroup、Seegene Inc.、Luminex Corporation、Certest Biotec、IMMY、Unigen Oy。 本節概述了競爭格局,包括各種戰略發展,例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。
注意:在公司簡介、財務細節、近期發展等方面,基於可用信息,私人控股公司可能不包括在內。
The global demand for Meningitis Diagnostic Testing Market is presumed to reach the market size of nearly USD 353.77 MN by 2030 from USD 209 MN in 2022 with a CAGR of 6.8% under the study period 2023 - 2030.
Meningitis is an inflammation of membranes called meninges surrounding the brain and spinal cord. Bacteria, viruses, parasites, and fungi cause this infection. Due to its propensity to spread like an epidemic, meningitis has become a topic of worry on a global scale. As a result, the government is actively working to eradicate meningitis by setting up high-tech diagnostic facilities and hospitals to provide patient care. Meningitis is diagnosed using a fast latex agglutination test or extremely sophisticated PCR, immunoassay, and other testing equipment.
The market is expected to rise due to increased consumer awareness of the need for early disease detection, rising demand for quick diagnoses, and high test accuracy. Additionally, the growing number of diagnostic facilities and government funding to lessen disease burden drive market demand. Furthermore, the meningitis diagnostic market's development is fueled by new cutting-edge technologies like PCR and next-generation sequencing that offer a less expensive diagnosis. During the projection period, several issues, including a lack of diagnostic laboratory facilities in emerging nations and a scarcity of specialists in meningitis diagnosis, are projected to restrain market expansion.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of meningitis diagnostic testing. The growth and trends of meningitis diagnostic testing industry provide a holistic approach to this study.
This section of the meningitis diagnostic testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Meningitis Diagnostic Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the meningitis diagnostic testing market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Abbott, ELITechGroup, Seegene Inc., Luminex Corporation, Certest Biotec, IMMY, Uniogen Oy. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.